Metagenomi, Inc. (NASDAQ: MGX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT METAGENOMI, INC.

Metagenomi, Inc. (NASDAQ: MGX)
Listen to this Section


$1.34
+0.0050 ( +0.38% ) 0.2K

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Market Data


Open $1.34
Previous Close $1.33
Volume 0.2K
Market Cap $50.07M
Day Range $1.33 - $1.34
52 Week Range $1.24 - $3.95
Shares Outstanding 37.65M
Change % +0.38%
Net Change ▲ 0.0050
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2024
CountryUnited States
UnderwriterJ.P. Morgan, Jefferies, TD Cowen, Wells Fargo Securities, BMO Capital Markets, Chardan Capital Markets, more

Insider Ownership Transactions

Total Amount Purchased: -355,899.00

Date Type Amount Purchased Purchaser
2024-04-03 Sale -57763.00 Noonberg Sarah B.
2024-04-03 Sale -69316.00 Wapnick Pamela
2024-04-03 Sale -10397.00 Wein Matthew
2024-04-03 Sale -69316.00 Borges Luis
2024-04-03 Sale -78636.00 Eckhardt Juergen
2024-04-03 Sale -70471.00 Irish Jian

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 61 Nov 12, 2025
8-k 8K-related 36 Nov 12, 2025
8-k 8K-related 10 Oct 01, 2025
4 Insider transactions 1 Sep 02, 2025
3 Insider transactions 2 Aug 15, 2025
8-k 8K-related 44 Aug 12, 2025
10-q Quarterly Reports 60 Aug 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy